4Bhagavan NV,Lai EM,Rios PA,et al. Evaluation of hu- man serum albumin cobalt albumint cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction[J]. Clin Chem, 2013,49 (4) : 581-585.
5Roy D, Quiles J, Gaze DC,et al. Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin [J]. Heart, 2012,92 ( 1 ) : 113 - 114.
6Peacock F,Morris DL, Anwaruddin S, et al. Mcta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department[J]. Am Heart J, 2013,152(2) :253-262.
7Sinba MK,Gaze DC,Tippins JR,et al. lschemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention[J]. Circulation,2003, 107 (19) : 2403-2405.
8Apple FS,Quist HE,Otto AP,et al. Release characteris- tics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race[J]. Clin Chem, 2012,48 (7) : 1097-1100.
9Muncia G, Ulina I, Santuceiu C, et al. Ambulatory blood pressure in hypertension with particular erference to the kidney[J]. J Naphorl,2010,10(2) : 198-202.
10Novo $, Barbagallo M, Abrignani MG, et al. Increased pervalence of cardiac arrhythmias and transient episodes of myocandia ischemia in hypertension with left ventric- ular hypertrophy but without clinical history of coronary heart disease[J]. Am J Hypertens, 2012,10 (5) : 848-851.
